ijms-logo

Journal Browser

Journal Browser

Molecular Mechanisms at the Intersection of Protein Synthesis, Cancer, and Immunity

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Immunology".

Deadline for manuscript submissions: closed (20 April 2025) | Viewed by 914

Special Issue Editors


E-Mail Website
Guest Editor
Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA
Interests: immune regulation; T cells; immune suppression; anti-tumor immunity; immunotherapy

E-Mail Website
Guest Editor
Department of Biological Sciences, University at Buffalo, The State University of New York, Buffalo, NY 14263, USA
Interests: ribosome; translation intiation; translational control; eIF4; DEAD box; mRNA; eukaryotic translation

Special Issue Information

Dear Colleagues,

Dysregulated protein synthesis is a common feature of malignancies. Tumor-associated perturbations in the expression and activity of the translation machinery have been repeatedly shown to impact the intrinsic traits and processes thought to drive aggressive phenotypes and poor outcomes in cancer patients. Recent advances have evidenced that the interface between tumors and the immune defenses (i.e., immune evasion vs. immune-mediated destruction) is impacted by the regulation of translation-level mechanisms. With several key molecular and cellular regulators of immune activity and suppression potentially under the sway of physiological and malignant translation, a better understanding of the interplay between translational control, immune regulation, and/or cancer progression may shed light on the failure of endogenous and therapy-induced anti-tumor immune responses, thus presenting opporunities for intervention.

In this Special Issue, we seek to compile original research articles, reviews, and case reports that expand on the compelling, but under-appreciated, intersection of translational control with immunoregulatory and cancer-promoting mechanisms. Highlighting this area of study, we aim to encourage mutlidisciplinary investigations to improve our understanding of the molecular mechanisms underlying immunity and cancer progression. The insights gained may uncover translation-relevant prognostic factors and candidate targets for therapy that may be used to personalize the care and treatment of patients with difficult-to-treat cancers.

Dr. Joseph Barbi
Dr. Sarah E. Walker
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • translation
  • protein synthesis
  • immunology
  • tumor
  • cancer
  • immune suppression
  • initiation
  • elongation
  • eukaryotic initiation factors
  • ribosome

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

29 pages, 216550 KiB  
Article
Integrating Bulk and Single-Cell Transcriptomics with Machine Learning Reveals a Heme Metabolism-Based Panel for Lung Adenocarcinoma Chemotherapy Resistance
by Lin Zhao, Haibo Han, Xuantong Zhou, Tongyang Gong, Yuge Zhu, Bufan Xiao, Shuchang Liu, Wei Zhao and Nan Wu
Int. J. Mol. Sci. 2025, 26(10), 4685; https://doi.org/10.3390/ijms26104685 - 14 May 2025
Viewed by 286
Abstract
Lung adenocarcinoma (LUAD) is a leading cause of cancer-related mortality, with heme metabolism playing a critical role in tumor progression and treatment resistance. This study investigates the clinical implications of heme metabolism in LUAD, focusing on its link to ferroptosis and drug sensitivity. [...] Read more.
Lung adenocarcinoma (LUAD) is a leading cause of cancer-related mortality, with heme metabolism playing a critical role in tumor progression and treatment resistance. This study investigates the clinical implications of heme metabolism in LUAD, focusing on its link to ferroptosis and drug sensitivity. Using multi-omics data from TCGA-LUAD, GEO databases, and a single-cell RNA-seq cohort, we identified two molecular subtypes based on heme metabolism-related genes. We further developed a prognostic panel, termed the heme metabolism risk score (HMRS), using LASSO and multivariate Cox regression analyses. The HMRS panel effectively stratified patients into high- and low-risk groups, with high-risk patients showing enhanced tumor proliferation, suppressed ferroptosis, and resistance to chemotherapy. Single-cell analysis revealed elevated heme metabolism risk in epithelial cells correlated with tumor progression. Drug sensitivity predictions were validated in platinum-based chemotherapy cohorts, confirming HMRS as a robust prognostic tool. ABCC2 was identified as a key regulator of ferroptosis and cisplatin resistance, with in vitro experiments demonstrating that ABCC2 knockdown enhanced cisplatin-induced ferroptosis. These findings highlight HMRS as a critical tool for patient stratification and ABCC2 as a promising therapeutic target to overcome cisplatin resistance. Full article
Show Figures

Figure 1

Back to TopTop